世界のマイクロRNA逆転写市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global MicroRNA Reverse Transcription Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5253
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、マイクロRNA逆転写の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（器具、キット＆試薬、消耗品）、用途別市場規模（がん、腎臓病、神経疾患、心血管疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・マイクロRNA逆転写の市場動向
・企業の競争状況、市場シェア
・マイクロRNA逆転写の種類別市場規模と予測2016-2027（器具、キット＆試薬、消耗品）
・マイクロRNA逆転写の用途別市場規模と予測2016-2027（がん、腎臓病、神経疾患、心血管疾患、その他）
・マイクロRNA逆転写の北米市場規模2016-2027（アメリカ、カナダ）
・マイクロRNA逆転写の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・マイクロRNA逆転写のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・マイクロRNA逆転写の中南米市場規模2016-2027（メキシコ、ブラジル）
・マイクロRNA逆転写の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sigma Aldrich Corp.、Thermo Fisher Scientific、Agilent Technologies、Illumina, Inc.、Bio-Rad Laboratories Inc.、System Biosciences LLC、HTG Molecular Diagnostics, Inc.、GeneCopoeia, Inc.、New England Biolabs, Inc.）
・結論

MicroRNA are small endogenous RNA that regulates gene-expression post-transcriptionally. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of the human and other mammals. MiRNA reverse transcription are crucial regulators of gene expression and promising candidates for biomarker development. A single miRNA can target hundreds of mRNAs and influence the expression of many genes. Further, miRNA reverse transcription involved in many allergies’ diseases including eosinophilic esophagitis, asthma and many others which is likely to increase the demand for MicroRNA Reverse Transcription. Current methodologies used for MicroRNA reverse transcription such as RNA-sequencing, microarrays and quantitative PCR.

Market Analysis and Insights: Global MicroRNA Reverse Transcription Market
The global MicroRNA Reverse Transcription market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global MicroRNA Reverse Transcription market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global MicroRNA Reverse Transcription market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global MicroRNA Reverse Transcription market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global MicroRNA Reverse Transcription market.

Global MicroRNA Reverse Transcription Scope and Market Size
MicroRNA Reverse Transcription market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global MicroRNA Reverse Transcription market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instruments
Kits & Reagents
Consumables

Segment by Application
Cancer
Kidney Disease
Neurological Disease
Cardiovascular Disease
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sigma Aldrich Corp.
Thermo Fisher Scientific
Agilent Technologies
Illumina, Inc.
Bio-Rad Laboratories Inc.
System Biosciences LLC
HTG Molecular Diagnostics, Inc.
GeneCopoeia, Inc.
New England Biolabs, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MicroRNA Reverse Transcription Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments
1.2.3 Kits & Reagents
1.2.4 Consumables
1.3 Market by Application
1.3.1 Global MicroRNA Reverse Transcription Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Kidney Disease
1.3.4 Neurological Disease
1.3.5 Cardiovascular Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global MicroRNA Reverse Transcription Market Perspective (2016-2027)
2.2 MicroRNA Reverse Transcription Growth Trends by Regions
2.2.1 MicroRNA Reverse Transcription Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 MicroRNA Reverse Transcription Historic Market Share by Regions (2016-2021)
2.2.3 MicroRNA Reverse Transcription Forecasted Market Size by Regions (2022-2027)
2.3 MicroRNA Reverse Transcription Industry Dynamic
2.3.1 MicroRNA Reverse Transcription Market Trends
2.3.2 MicroRNA Reverse Transcription Market Drivers
2.3.3 MicroRNA Reverse Transcription Market Challenges
2.3.4 MicroRNA Reverse Transcription Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top MicroRNA Reverse Transcription Players by Revenue
3.1.1 Global Top MicroRNA Reverse Transcription Players by Revenue (2016-2021)
3.1.2 Global MicroRNA Reverse Transcription Revenue Market Share by Players (2016-2021)
3.2 Global MicroRNA Reverse Transcription Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by MicroRNA Reverse Transcription Revenue
3.4 Global MicroRNA Reverse Transcription Market Concentration Ratio
3.4.1 Global MicroRNA Reverse Transcription Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MicroRNA Reverse Transcription Revenue in 2020
3.5 MicroRNA Reverse Transcription Key Players Head office and Area Served
3.6 Key Players MicroRNA Reverse Transcription Product Solution and Service
3.7 Date of Enter into MicroRNA Reverse Transcription Market
3.8 Mergers & Acquisitions, Expansion Plans

4 MicroRNA Reverse Transcription Breakdown Data by Type
4.1 Global MicroRNA Reverse Transcription Historic Market Size by Type (2016-2021)
4.2 Global MicroRNA Reverse Transcription Forecasted Market Size by Type (2022-2027)

5 MicroRNA Reverse Transcription Breakdown Data by Application
5.1 Global MicroRNA Reverse Transcription Historic Market Size by Application (2016-2021)
5.2 Global MicroRNA Reverse Transcription Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America MicroRNA Reverse Transcription Market Size (2016-2027)
6.2 North America MicroRNA Reverse Transcription Market Size by Type
6.2.1 North America MicroRNA Reverse Transcription Market Size by Type (2016-2021)
6.2.2 North America MicroRNA Reverse Transcription Market Size by Type (2022-2027)
6.2.3 North America MicroRNA Reverse Transcription Market Size by Type (2016-2027)
6.3 North America MicroRNA Reverse Transcription Market Size by Application
6.3.1 North America MicroRNA Reverse Transcription Market Size by Application (2016-2021)
6.3.2 North America MicroRNA Reverse Transcription Market Size by Application (2022-2027)
6.3.3 North America MicroRNA Reverse Transcription Market Size by Application (2016-2027)
6.4 North America MicroRNA Reverse Transcription Market Size by Country
6.4.1 North America MicroRNA Reverse Transcription Market Size by Country (2016-2021)
6.4.2 North America MicroRNA Reverse Transcription Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe MicroRNA Reverse Transcription Market Size (2016-2027)
7.2 Europe MicroRNA Reverse Transcription Market Size by Type
7.2.1 Europe MicroRNA Reverse Transcription Market Size by Type (2016-2021)
7.2.2 Europe MicroRNA Reverse Transcription Market Size by Type (2022-2027)
7.2.3 Europe MicroRNA Reverse Transcription Market Size by Type (2016-2027)
7.3 Europe MicroRNA Reverse Transcription Market Size by Application
7.3.1 Europe MicroRNA Reverse Transcription Market Size by Application (2016-2021)
7.3.2 Europe MicroRNA Reverse Transcription Market Size by Application (2022-2027)
7.3.3 Europe MicroRNA Reverse Transcription Market Size by Application (2016-2027)
7.4 Europe MicroRNA Reverse Transcription Market Size by Country
7.4.1 Europe MicroRNA Reverse Transcription Market Size by Country (2016-2021)
7.4.2 Europe MicroRNA Reverse Transcription Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific MicroRNA Reverse Transcription Market Size (2016-2027)
8.2 Asia-Pacific MicroRNA Reverse Transcription Market Size by Type
8.2.1 Asia-Pacific MicroRNA Reverse Transcription Market Size by Type (2016-2021)
8.2.2 Asia-Pacific MicroRNA Reverse Transcription Market Size by Type (2022-2027)
8.2.3 Asia-Pacific MicroRNA Reverse Transcription Market Size by Type (2016-2027)
8.3 Asia-Pacific MicroRNA Reverse Transcription Market Size by Application
8.3.1 Asia-Pacific MicroRNA Reverse Transcription Market Size by Application (2016-2021)
8.3.2 Asia-Pacific MicroRNA Reverse Transcription Market Size by Application (2022-2027)
8.3.3 Asia-Pacific MicroRNA Reverse Transcription Market Size by Application (2016-2027)
8.4 Asia-Pacific MicroRNA Reverse Transcription Market Size by Region
8.4.1 Asia-Pacific MicroRNA Reverse Transcription Market Size by Region (2016-2021)
8.4.2 Asia-Pacific MicroRNA Reverse Transcription Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America MicroRNA Reverse Transcription Market Size (2016-2027)
9.2 Latin America MicroRNA Reverse Transcription Market Size by Type
9.2.1 Latin America MicroRNA Reverse Transcription Market Size by Type (2016-2021)
9.2.2 Latin America MicroRNA Reverse Transcription Market Size by Type (2022-2027)
9.2.3 Latin America MicroRNA Reverse Transcription Market Size by Type (2016-2027)
9.3 Latin America MicroRNA Reverse Transcription Market Size by Application
9.3.1 Latin America MicroRNA Reverse Transcription Market Size by Application (2016-2021)
9.3.2 Latin America MicroRNA Reverse Transcription Market Size by Application (2022-2027)
9.3.3 Latin America MicroRNA Reverse Transcription Market Size by Application (2016-2027)
9.4 Latin America MicroRNA Reverse Transcription Market Size by Country
9.4.1 Latin America MicroRNA Reverse Transcription Market Size by Country (2016-2021)
9.4.2 Latin America MicroRNA Reverse Transcription Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa MicroRNA Reverse Transcription Market Size (2016-2027)
10.2 Middle East & Africa MicroRNA Reverse Transcription Market Size by Type
10.2.1 Middle East & Africa MicroRNA Reverse Transcription Market Size by Type (2016-2021)
10.2.2 Middle East & Africa MicroRNA Reverse Transcription Market Size by Type (2022-2027)
10.2.3 Middle East & Africa MicroRNA Reverse Transcription Market Size by Type (2016-2027)
10.3 Middle East & Africa MicroRNA Reverse Transcription Market Size by Application
10.3.1 Middle East & Africa MicroRNA Reverse Transcription Market Size by Application (2016-2021)
10.3.2 Middle East & Africa MicroRNA Reverse Transcription Market Size by Application (2022-2027)
10.3.3 Middle East & Africa MicroRNA Reverse Transcription Market Size by Application (2016-2027)
10.4 Middle East & Africa MicroRNA Reverse Transcription Market Size by Country
10.4.1 Middle East & Africa MicroRNA Reverse Transcription Market Size by Country (2016-2021)
10.4.2 Middle East & Africa MicroRNA Reverse Transcription Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sigma Aldrich Corp.
11.1.1 Sigma Aldrich Corp. Company Details
11.1.2 Sigma Aldrich Corp. Business Overview
11.1.3 Sigma Aldrich Corp. MicroRNA Reverse Transcription Introduction
11.1.4 Sigma Aldrich Corp. Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.1.5 Sigma Aldrich Corp. Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific MicroRNA Reverse Transcription Introduction
11.2.4 Thermo Fisher Scientific Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies MicroRNA Reverse Transcription Introduction
11.3.4 Agilent Technologies Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Details
11.4.2 Illumina, Inc. Business Overview
11.4.3 Illumina, Inc. MicroRNA Reverse Transcription Introduction
11.4.4 Illumina, Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.4.5 Illumina, Inc. Recent Development
11.5 Bio-Rad Laboratories Inc.
11.5.1 Bio-Rad Laboratories Inc. Company Details
11.5.2 Bio-Rad Laboratories Inc. Business Overview
11.5.3 Bio-Rad Laboratories Inc. MicroRNA Reverse Transcription Introduction
11.5.4 Bio-Rad Laboratories Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.5.5 Bio-Rad Laboratories Inc. Recent Development
11.6 System Biosciences LLC
11.6.1 System Biosciences LLC Company Details
11.6.2 System Biosciences LLC Business Overview
11.6.3 System Biosciences LLC MicroRNA Reverse Transcription Introduction
11.6.4 System Biosciences LLC Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.6.5 System Biosciences LLC Recent Development
11.7 HTG Molecular Diagnostics, Inc.
11.7.1 HTG Molecular Diagnostics, Inc. Company Details
11.7.2 HTG Molecular Diagnostics, Inc. Business Overview
11.7.3 HTG Molecular Diagnostics, Inc. MicroRNA Reverse Transcription Introduction
11.7.4 HTG Molecular Diagnostics, Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.7.5 HTG Molecular Diagnostics, Inc. Recent Development
11.8 GeneCopoeia, Inc.
11.8.1 GeneCopoeia, Inc. Company Details
11.8.2 GeneCopoeia, Inc. Business Overview
11.8.3 GeneCopoeia, Inc. MicroRNA Reverse Transcription Introduction
11.8.4 GeneCopoeia, Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.8.5 GeneCopoeia, Inc. Recent Development
11.9 New England Biolabs, Inc.
11.9.1 New England Biolabs, Inc. Company Details
11.9.2 New England Biolabs, Inc. Business Overview
11.9.3 New England Biolabs, Inc. MicroRNA Reverse Transcription Introduction
11.9.4 New England Biolabs, Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021)
11.9.5 New England Biolabs, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global MicroRNA Reverse Transcription Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instruments
Table 3. Key Players of Kits & Reagents
Table 4. Key Players of Consumables
Table 5. Global MicroRNA Reverse Transcription Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global MicroRNA Reverse Transcription Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global MicroRNA Reverse Transcription Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global MicroRNA Reverse Transcription Market Share by Regions (2016-2021)
Table 9. Global MicroRNA Reverse Transcription Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global MicroRNA Reverse Transcription Market Share by Regions (2022-2027)
Table 11. MicroRNA Reverse Transcription Market Trends
Table 12. MicroRNA Reverse Transcription Market Drivers
Table 13. MicroRNA Reverse Transcription Market Challenges
Table 14. MicroRNA Reverse Transcription Market Restraints
Table 15. Global MicroRNA Reverse Transcription Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global MicroRNA Reverse Transcription Market Share by Players (2016-2021)
Table 17. Global Top MicroRNA Reverse Transcription Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MicroRNA Reverse Transcription as of 2020)
Table 18. Ranking of Global Top MicroRNA Reverse Transcription Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by MicroRNA Reverse Transcription Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players MicroRNA Reverse Transcription Product Solution and Service
Table 22. Date of Enter into MicroRNA Reverse Transcription Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global MicroRNA Reverse Transcription Market Size by Type (2016-2021) (US$ Million)
Table 25. Global MicroRNA Reverse Transcription Revenue Market Share by Type (2016-2021)
Table 26. Global MicroRNA Reverse Transcription Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global MicroRNA Reverse Transcription Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global MicroRNA Reverse Transcription Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global MicroRNA Reverse Transcription Revenue Market Share by Application (2016-2021)
Table 30. Global MicroRNA Reverse Transcription Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global MicroRNA Reverse Transcription Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America MicroRNA Reverse Transcription Market Size by Type (2016-2021) (US$ Million)
Table 33. North America MicroRNA Reverse Transcription Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America MicroRNA Reverse Transcription Market Size by Application (2016-2021) (US$ Million)
Table 35. North America MicroRNA Reverse Transcription Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America MicroRNA Reverse Transcription Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America MicroRNA Reverse Transcription Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe MicroRNA Reverse Transcription Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe MicroRNA Reverse Transcription Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe MicroRNA Reverse Transcription Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe MicroRNA Reverse Transcription Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe MicroRNA Reverse Transcription Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe MicroRNA Reverse Transcription Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific MicroRNA Reverse Transcription Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific MicroRNA Reverse Transcription Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific MicroRNA Reverse Transcription Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific MicroRNA Reverse Transcription Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific MicroRNA Reverse Transcription Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific MicroRNA Reverse Transcription Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America MicroRNA Reverse Transcription Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America MicroRNA Reverse Transcription Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America MicroRNA Reverse Transcription Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America MicroRNA Reverse Transcription Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America MicroRNA Reverse Transcription Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America MicroRNA Reverse Transcription Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa MicroRNA Reverse Transcription Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa MicroRNA Reverse Transcription Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa MicroRNA Reverse Transcription Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa MicroRNA Reverse Transcription Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa MicroRNA Reverse Transcription Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa MicroRNA Reverse Transcription Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sigma Aldrich Corp. Company Details
Table 63. Sigma Aldrich Corp. Business Overview
Table 64. Sigma Aldrich Corp. MicroRNA Reverse Transcription Product
Table 65. Sigma Aldrich Corp. Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 66. Sigma Aldrich Corp. Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific MicroRNA Reverse Transcription Product
Table 70. Thermo Fisher Scientific Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. Agilent Technologies Company Details
Table 73. Agilent Technologies Business Overview
Table 74. Agilent Technologies MicroRNA Reverse Transcription Product
Table 75. Agilent Technologies Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 76. Agilent Technologies Recent Development
Table 77. Illumina, Inc. Company Details
Table 78. Illumina, Inc. Business Overview
Table 79. Illumina, Inc. MicroRNA Reverse Transcription Product
Table 80. Illumina, Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 81. Illumina, Inc. Recent Development
Table 82. Bio-Rad Laboratories Inc. Company Details
Table 83. Bio-Rad Laboratories Inc. Business Overview
Table 84. Bio-Rad Laboratories Inc. MicroRNA Reverse Transcription Product
Table 85. Bio-Rad Laboratories Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 86. Bio-Rad Laboratories Inc. Recent Development
Table 87. System Biosciences LLC Company Details
Table 88. System Biosciences LLC Business Overview
Table 89. System Biosciences LLC MicroRNA Reverse Transcription Product
Table 90. System Biosciences LLC Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 91. System Biosciences LLC Recent Development
Table 92. HTG Molecular Diagnostics, Inc. Company Details
Table 93. HTG Molecular Diagnostics, Inc. Business Overview
Table 94. HTG Molecular Diagnostics, Inc. MicroRNA Reverse Transcription Product
Table 95. HTG Molecular Diagnostics, Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 96. HTG Molecular Diagnostics, Inc. Recent Development
Table 97. GeneCopoeia, Inc. Company Details
Table 98. GeneCopoeia, Inc. Business Overview
Table 99. GeneCopoeia, Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 100. GeneCopoeia, Inc. Recent Development
Table 101. New England Biolabs, Inc. Company Details
Table 102. New England Biolabs, Inc. Business Overview
Table 103. New England Biolabs, Inc. MicroRNA Reverse Transcription Product
Table 104. New England Biolabs, Inc. Revenue in MicroRNA Reverse Transcription Business (2016-2021) & (US$ Million)
Table 105. New England Biolabs, Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global MicroRNA Reverse Transcription Market Share by Type: 2020 VS 2027
Figure 2. Instruments Features
Figure 3. Kits & Reagents Features
Figure 4. Consumables Features
Figure 5. Global MicroRNA Reverse Transcription Market Share by Application: 2020 VS 2027
Figure 6. Cancer Case Studies
Figure 7. Kidney Disease Case Studies
Figure 8. Neurological Disease Case Studies
Figure 9. Cardiovascular Disease Case Studies
Figure 10. Others Case Studies
Figure 11. MicroRNA Reverse Transcription Report Years Considered
Figure 12. Global MicroRNA Reverse Transcription Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global MicroRNA Reverse Transcription Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global MicroRNA Reverse Transcription Market Share by Regions: 2020 VS 2027
Figure 15. Global MicroRNA Reverse Transcription Market Share by Regions (2022-2027)
Figure 16. Global MicroRNA Reverse Transcription Market Share by Players in 2020
Figure 17. Global Top MicroRNA Reverse Transcription Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MicroRNA Reverse Transcription as of 2020
Figure 18. The Top 10 and 5 Players Market Share by MicroRNA Reverse Transcription Revenue in 2020
Figure 19. Global MicroRNA Reverse Transcription Revenue Market Share by Type (2016-2021)
Figure 20. Global MicroRNA Reverse Transcription Revenue Market Share by Type (2022-2027)
Figure 21. North America MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America MicroRNA Reverse Transcription Market Share by Type (2016-2027)
Figure 23. North America MicroRNA Reverse Transcription Market Share by Application (2016-2027)
Figure 24. North America MicroRNA Reverse Transcription Market Share by Country (2016-2027)
Figure 25. United States MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe MicroRNA Reverse Transcription Market Share by Type (2016-2027)
Figure 29. Europe MicroRNA Reverse Transcription Market Share by Application (2016-2027)
Figure 30. Europe MicroRNA Reverse Transcription Market Share by Country (2016-2027)
Figure 31. Germany MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific MicroRNA Reverse Transcription Market Share by Type (2016-2027)
Figure 39. Asia-Pacific MicroRNA Reverse Transcription Market Share by Application (2016-2027)
Figure 40. Asia-Pacific MicroRNA Reverse Transcription Market Share by Region (2016-2027)
Figure 41. China MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America MicroRNA Reverse Transcription Market Share by Type (2016-2027)
Figure 49. Latin America MicroRNA Reverse Transcription Market Share by Application (2016-2027)
Figure 50. Latin America MicroRNA Reverse Transcription Market Share by Country (2016-2027)
Figure 51. Mexico MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa MicroRNA Reverse Transcription Market Share by Type (2016-2027)
Figure 55. Middle East & Africa MicroRNA Reverse Transcription Market Share by Application (2016-2027)
Figure 56. Middle East & Africa MicroRNA Reverse Transcription Market Share by Country (2016-2027)
Figure 57. Turkey MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE MicroRNA Reverse Transcription Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sigma Aldrich Corp. Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 62. Agilent Technologies Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 63. Illumina, Inc. Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 64. Bio-Rad Laboratories Inc. Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 65. System Biosciences LLC Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 66. HTG Molecular Diagnostics, Inc. Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 67. GeneCopoeia, Inc. Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 68. New England Biolabs, Inc. Revenue Growth Rate in MicroRNA Reverse Transcription Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の逆転写酵素市場規模・現状・予測（2021年-2027年）

Global Reverse Transcriptase Enzyme Market Size, Status and Forecast 2021-2027
QFJ1-4832 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、逆転写酵素の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（逆転写酵素酵素試薬、逆転写酵素プライマー）、用途別市場規模（病院、バイオテクノロジー企業、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

逆転写酵素のグローバル市場2021

Global Reverse Transcriptase Sales Market Report 2021
QAF27878 2021年4月2日 142Pages
本市場調査資料では、世界の逆転写酵素市場について種類別（MMLV逆転写酵素、AMV逆転写酵素）、用途別（PCR、シーケンシング、クローニング）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）...

世界の肝炎ウイルス診断検査市場規模・現状・予測（2021年-2027年）

Global Hepatitis Viruses Diagnostic Tests Market Size, Status and Forecast 2021-2027
QFJ1-4304 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、肝炎ウイルス診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素免疫測定法（EIA）、組換免疫ブロット法（RIBA）、転写媒介増幅法（TMA）、ポリメラーゼ連鎖反応法（PCR）、その他）、用途...

リバース自動販売機のグローバル市場2021

Global Reverse Vending Machine Sales Market Report 2021
QAF26388 2021年4月7日 136Pages
本市場調査資料では、世界のリバース自動販売機市場について種類別（詰め替え不可タイプ、詰め替えタイプ、多機能タイプ）、用途別（スーパーマーケット、コミュニティ、ユーティリティ）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場...

世界の新規抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Novel Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4596 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、新規抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター、その他）、用途別市場規模（肝炎治療、HIV/AIDS治療、ヘルペ...

海水逆浸透海水淡水化ポンプのグローバル市場2021

Global Seawater Reverse Osmosis Desalination Pump Sales Market Report 2021
QAF26478 2021年4月20日 143Pages
本市場調査資料では、世界の海水逆浸透海水淡水化ポンプ市場について種類別（遠心ポンプ、容積式ポンプ）、用途別（工業用、都市用、農業・飲料水、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のインフルエンザ (Flu) 抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Influenza (Flu) Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5801 2021年6月 121Pages
QYResearch社発行の本調査レポートでは、インフルエンザ (Flu) 抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（浸透＆剥離阻害剤、DNAポリメラーゼ阻害剤、逆転写酵素阻害剤、タンパク質阻害剤、ノイラミニダーゼ阻害剤、広域スペ...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Drugs Market The global Polycystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
世界のAPOL1関与腎臓病市場規模・現状・予測（2021年-2027年） APOL1 gene is a member of APOL gene family, which plays an important role in innate immunity, which is our body’s built-in defense system to fight threats. Some variations in APOL1 gene cause damage to parts within the kidney. Damage to parts that filter blood can lead to severe kidney disease or ul…
世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Cystic Kidney Disease Treatment Drugs Market The global Acquired Cystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accura…
世界の常染色体優性多発性嚢胞腎用治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autosomal Dominant Polycystic Kidney Disease Treatment Market The global Autosomal Dominant Polycystic Kidney Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry…
世界の後期慢性腎臓病治療薬市場規模・現状・予測（2021年-2027年） Late stage chronic kidney disease therapeutics can be defined as the drugs which are used for the treatment of late-stage CKD - Induced, Hyperphosphatemia, Hyperparathyroidism and Hyperkalemia. Market Analysis and Insights: Global Late Stage Chronic Kidney Disease Drugs Market The global Late Stage …